Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes
- PMID: 14749275
- DOI: 10.2337/diabetes.53.2007.s110
Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes
Abstract
Hyperglycemia causes many of the pathological consequences of both type 1 and type 2 diabetes. Much of this damage is suggested to be a consequence of elevated production of reactive oxygen species by the mitochondrial respiratory chain during hyperglycemia. Mitochondrial radical production associated with hyperglycemia will also disrupt glucose-stimulated insulin secretion by pancreatic beta-cells, because pancreatic beta-cells are particularly susceptible to oxidative damage. Therefore, mitochondrial radical production in response to hyperglycemia contributes to both the progression and pathological complications of diabetes. Consequently, strategies to decrease mitochondrial radical production and oxidative damage may have therapeutic potential. This could be achieved by the use of antioxidants or by decreasing the mitochondrial membrane potential. Here, we outline the background to these strategies and discuss how antioxidants targeted to mitochondria, or selective mitochondrial uncoupling, may be potential therapies for diabetes.
Similar articles
-
Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress.Exp Diabetes Res. 2012;2012:696215. doi: 10.1155/2012/696215. Epub 2012 Jan 2. Exp Diabetes Res. 2012. PMID: 22253615 Free PMC article. Review.
-
Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.Toxicol Appl Pharmacol. 2006 Apr 15;212(2):167-78. doi: 10.1016/j.taap.2006.01.003. Epub 2006 Feb 20. Toxicol Appl Pharmacol. 2006. PMID: 16490224 Review.
-
Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.Free Radic Biol Med. 2016 Jan;90:12-23. doi: 10.1016/j.freeradbiomed.2015.11.013. Epub 2015 Nov 11. Free Radic Biol Med. 2016. PMID: 26577173 Free PMC article.
-
Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants.Infect Disord Drug Targets. 2009 Aug;9(4):376-89. doi: 10.2174/187152609788922519. Infect Disord Drug Targets. 2009. PMID: 19689380 Review.
-
Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells.Toxicol Appl Pharmacol. 2012 Mar 15;259(3):395-401. doi: 10.1016/j.taap.2011.09.028. Epub 2011 Oct 10. Toxicol Appl Pharmacol. 2012. PMID: 22015446
Cited by
-
Diabetes and alpha lipoic Acid.Front Pharmacol. 2011 Nov 17;2:69. doi: 10.3389/fphar.2011.00069. eCollection 2011. Front Pharmacol. 2011. PMID: 22125537 Free PMC article.
-
Quantitative measurement of mitochondrial membrane potential in cultured cells: calcium-induced de- and hyperpolarization of neuronal mitochondria.J Physiol. 2012 Jun 15;590(12):2845-71. doi: 10.1113/jphysiol.2012.228387. Epub 2012 Apr 10. J Physiol. 2012. PMID: 22495585 Free PMC article.
-
Potential therapeutic benefits of strategies directed to mitochondria.Antioxid Redox Signal. 2010 Aug 1;13(3):279-347. doi: 10.1089/ars.2009.2788. Antioxid Redox Signal. 2010. PMID: 20001744 Free PMC article. Review.
-
An anti-diabetic drug targets NEET (CISD) proteins through destabilization of their [2Fe-2S] clusters.Commun Biol. 2022 May 10;5(1):437. doi: 10.1038/s42003-022-03393-x. Commun Biol. 2022. PMID: 35538231 Free PMC article.
-
Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy.Cell Death Dis. 2018 Aug 6;9(8):837. doi: 10.1038/s41419-018-0861-x. Cell Death Dis. 2018. PMID: 30082798 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
